About Transcend Medical
Transcend Medical is a company based in Menlo Park (United States) founded in 2006 was acquired by Alcon in February 2016. Transcend Medical has raised $122.27 million across 4 funding rounds from investors including Alcon, Canaan and Finistere Ventures. The company has 20 employees as of December 31, 2017. Transcend Medical operates in a competitive market with competitors including Glaukos, Myra Vision, Ivantis, Sensimed and Avisi Technologies, among others.
- Headquarter Menlo Park, United States
- Employees 20 as on 31 Dec, 2017
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Transcend Medical, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Transcend Medical
Transcend Medical has successfully raised a total of $122.27M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $29.27 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Transcend Medical
Transcend Medical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Alcon, Canaan and Finistere Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
VC firm investing in expansion stage tech and life sciences companies in the US
|
Locked | Locked | Locked |
Investor details for Transcend Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Transcend Medical
Investment portfolio details for Transcend Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Transcend Medical
Detailed financials for Transcend Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Transcend Medical Comparisons
Peer comparison for Transcend Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Transcend Medical
Transcend Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Glaukos, Myra Vision, Ivantis, Sensimed and Avisi Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of implants to treat glaucoma
|
|
| Locked | Locked | Locked |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| Locked | Locked | Locked |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| Locked | Locked | Locked |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| Locked | Locked | Locked |
Nano-materials for glaucoma treatment implants are developed.
|
Detailed competitors of Transcend Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Transcend Medical
Complete news archive for Transcend Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Transcend Medical
Transcend Medical was founded in 2006.
Transcend Medical is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Transcend Medical is a funded company, having raised a total of $122.27M across 4 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Transcend Medical is 20.
Transcend Medical was founded in 2006 and is headquartered in Menlo Park, United States. Medical devices for minimally invasive glaucoma interventions are developed by the company within the ophthalmology sector. The CyPass Micro-Stent, implanted in the supraciliary space, is designed to reduce intraocular pressure by creating a micro-cyclodialysis that bypasses the ciliary body and targets the suprachoroidal outflow pathway, similar to prostaglandin analogues.
Transcend Medical's top competitors include Glaukos, Myra Vision and Avisi Technologies.
Transcend Medical has 10 investors. Key investors include Alcon, Canaan, Finistere Ventures, HLM Venture Partners, and Kaiser Permanente Ventures.